 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - Foamix Pharmaceuticals Ltd. (FOMX)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> SPAC List: List of Special Purpose Acquisition Companies |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-08-26 Sale | 2019-08-28 4:36 pm | Foamix Pharmaceuticals Ltd. | FOMX | KAZANCHYAN ANNA Director | 7,049 | $3.27 | $23,050 | 37,498 (Direct) | View |
| 2019-09-09 Sale | 2019-09-11 5:12 pm | Foamix Pharmaceuticals Ltd. | FOMX | Hadar Ilan CFO | 43,812 | $3.5006 | $153,366 | 89,279 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-09-30 Tax Withholding | 2019-10-02 4:18 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Domzalski David CEO | 2,256 | $3.07 | 208,984 (Direct) | View |
| 2019-09-30 Tax Withholding | 2019-10-02 4:19 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Harsch Mutya CLO and General Counsel | 463 | $3.07 | 51,506 (Direct) | View |
| 2019-09-30 Tax Withholding | 2019-10-02 4:20 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Stuart Iain Chief Scientific Officer | 673 | $3.07 | 62,851 (Direct) | View |
| 2019-10-15 Exercise | 2019-10-17 4:11 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Hirsch Stanley Director | 90,000 | $0.62 | 150,000 (Indirect) | View |
| 2019-10-15 Exercise | 2019-10-17 4:11 pm | 2004-01-01 2019-11-25 | Foamix Pharmaceuticals Ltd. | FOMX | Hirsch Stanley Director | 90,000 | $0 | 32,500 (Indirect) | View |
| 2019-11-04 Exercise | 2019-11-05 4:32 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Hirsch Stanley Director | 32,500 | $0.62 | 182,500 (Indirect) | View |
| 2019-11-04 Exercise | 2019-11-05 4:32 pm | 2004-01-01 2019-11-25 | Foamix Pharmaceuticals Ltd. | FOMX | Hirsch Stanley Director | 32,500 | $0 | 0 (Indirect) | View |
| 2019-11-29 Option Award | 2019-12-03 4:30 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Harsch Mutya CLO and General Counsel | 4,284 | $2.159 | 55,790 (Direct) | View |
| 2019-11-29 Option Award | 2019-12-03 4:31 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Wiley Matthew T. Chief Commercial Officer | 9,842 | $2.159 | 73,282 (Direct) | View |
| 2019-11-29 Option Award | 2019-12-03 4:32 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Domzalski David CEO | 9,842 | $2.159 | 218,826 (Direct) | View |
| 2019-12-31 Tax Withholding | 2020-01-03 5:22 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Domzalski David CEO | 2,751 | $3.28 | 216,075 (Direct) | View |
| 2019-12-31 Tax Withholding | 2020-01-03 5:23 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Harsch Mutya CLO and General Counsel | 618 | $3.28 | 55,172 (Direct) | View |
| 2019-12-31 Tax Withholding | 2020-01-03 5:23 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Stuart Iain Chief Scientific Officer | 514 | $3.28 | 62,337 (Direct) | View |
| 2019-12-31 Tax Withholding | 2020-01-03 5:24 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Wiley Matthew T. Chief Commercial Officer | 2,500 | $3.28 | 70,782 (Direct) | View |
| 2020-02-24 Option Award | 2020-02-24 6:38 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Domzalski David CEO | 103,248 | $0 | 319,323 (Direct) | View |
| 2020-02-24 Option Award | 2020-02-24 6:38 pm | N/A 2030-02-24 | Foamix Pharmaceuticals Ltd. | FOMX | Domzalski David CEO | 240,912 | $0 | 240,912 (Direct) | View |
| 2020-02-24 Option Award | 2020-02-24 6:38 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Hadar Ilan CFO | 41,299 | $0 | 130,578 (Direct) | View |
| 2020-02-24 Option Award | 2020-02-24 6:38 pm | N/A 2030-02-24 | Foamix Pharmaceuticals Ltd. | FOMX | Hadar Ilan CFO | 96,365 | $0 | 96,365 (Direct) | View |
| 2020-02-24 Option Award | 2020-02-24 6:38 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Harsch Mutya CLO and General Counsel | 41,299 | $0 | 96,471 (Direct) | View |
| 2020-02-24 Option Award | 2020-02-24 6:38 pm | N/A 2030-02-24 | Foamix Pharmaceuticals Ltd. | FOMX | Harsch Mutya CLO and General Counsel | 96,365 | $0 | 96,365 (Direct) | View |
| 2020-02-24 Option Award | 2020-02-24 6:39 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Stuart Iain Chief Scientific Officer | 41,299 | $0 | 103,636 (Direct) | View |
| 2020-02-24 Option Award | 2020-02-24 6:39 pm | N/A 2030-02-24 | Foamix Pharmaceuticals Ltd. | FOMX | Stuart Iain Chief Scientific Officer | 96,365 | $0 | 96,365 (Direct) | View |
| 2020-02-24 Option Award | 2020-02-24 6:39 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Wiley Matthew T. Chief Commercial Officer | 41,299 | $0 | 112,081 (Direct) | View |
| 2020-02-24 Option Award | 2020-02-24 6:39 pm | N/A 2030-02-24 | Foamix Pharmaceuticals Ltd. | FOMX | Wiley Matthew T. Chief Commercial Officer | 96,365 | $0 | 96,365 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-03 4:31 pm | N/A 2030-02-27 | Foamix Pharmaceuticals Ltd. | FOMX | Bright Rex Director | 38,156 | $0 | 38,156 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-03 4:31 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Bruno Anthony D Director | 5,312 | $0 | 75,007 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-03 4:32 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Hirsch Stanley Director | 42,493 | $0 | 111,858 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-03 4:32 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | KAZANCHYAN ANNA Director | 21,246 | $0 | 58,744 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-03 4:33 pm | N/A 2030-02-27 | Foamix Pharmaceuticals Ltd. | FOMX | Schwartz Aharon Director | 38,156 | $0 | 38,156 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-03 4:36 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | STERN STANLEY Director | 14,164 | $0 | 42,359 (Direct) | View |
| 2020-02-27 Option Award | 2020-03-03 4:36 pm | N/A 2030-02-27 | Foamix Pharmaceuticals Ltd. | FOMX | STERN STANLEY Director | 12,719 | $0 | 12,719 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-03 4:38 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Domzalski David CEO | 4,705 | $2.6775 | 324,028 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-03 4:38 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Harsch Mutya CLO and General Counsel | 1,761 | $2.6775 | 98,232 (Direct) | View |
| 2020-03-02 Option Award | 2020-03-03 4:39 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Wiley Matthew T. Chief Commercial Officer | 1,993 | $2.6775 | 114,074 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:36 pm | N/A 2029-05-16 | Foamix Pharmaceuticals Ltd. | FOMX | BARBARI SHARON SURREY Director | 49,412 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:37 pm | N/A 2024-12-29 | Foamix Pharmaceuticals Ltd. | FOMX | Bright Rex Director | 27,000 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:37 pm | N/A 2027-07-12 | Foamix Pharmaceuticals Ltd. | FOMX | Bright Rex Director | 21,562 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:37 pm | N/A 2028-05-08 | Foamix Pharmaceuticals Ltd. | FOMX | Bright Rex Director | 24,947 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:37 pm | N/A 2029-05-16 | Foamix Pharmaceuticals Ltd. | FOMX | Bright Rex Director | 49,412 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:37 pm | N/A 2030-02-27 | Foamix Pharmaceuticals Ltd. | FOMX | Bright Rex Director | 38,156 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:37 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Bruno Anthony D Director | 62,647 | $0 | 12,360 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:37 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Bruno Anthony D Director | 12,360 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:38 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Domzalski David CEO | 90,902 | $0 | 233,126 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:38 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Domzalski David CEO | 233,126 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:38 pm | N/A 2024-06-09 | Foamix Pharmaceuticals Ltd. | FOMX | Domzalski David CEO | 18,750 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:38 pm | N/A 2025-11-10 | Foamix Pharmaceuticals Ltd. | FOMX | Domzalski David CEO | 236,810 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:38 pm | N/A 2026-03-01 | Foamix Pharmaceuticals Ltd. | FOMX | Domzalski David CEO | 60,000 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:38 pm | N/A 2027-01-01 | Foamix Pharmaceuticals Ltd. | FOMX | Domzalski David CEO | 71,369 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:38 pm | N/A 2027-08-08 | Foamix Pharmaceuticals Ltd. | FOMX | Domzalski David CEO | 327,720 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:38 pm | N/A 2028-02-27 | Foamix Pharmaceuticals Ltd. | FOMX | Domzalski David CEO | 70,187 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:38 pm | N/A 2029-01-01 | Foamix Pharmaceuticals Ltd. | FOMX | Domzalski David CEO | 170,993 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:38 pm | N/A 2030-02-24 | Foamix Pharmaceuticals Ltd. | FOMX | Domzalski David CEO | 240,912 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:38 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Hadar Ilan CFO | 14,077 | $0 | 116,501 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:38 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Hadar Ilan CFO | 116,501 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:38 pm | N/A 2024-03-31 | Foamix Pharmaceuticals Ltd. | FOMX | Hadar Ilan CFO | 5,469 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:38 pm | N/A 2024-11-19 | Foamix Pharmaceuticals Ltd. | FOMX | Hadar Ilan CFO | 24,125 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:38 pm | N/A 2025-01-15 | Foamix Pharmaceuticals Ltd. | FOMX | Hadar Ilan CFO | 18,000 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:38 pm | N/A 2025-11-10 | Foamix Pharmaceuticals Ltd. | FOMX | Hadar Ilan CFO | 202,004 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:38 pm | N/A 2026-03-01 | Foamix Pharmaceuticals Ltd. | FOMX | Hadar Ilan CFO | 60,000 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:38 pm | N/A 2027-01-01 | Foamix Pharmaceuticals Ltd. | FOMX | Hadar Ilan CFO | 60,389 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:38 pm | N/A 2027-08-08 | Foamix Pharmaceuticals Ltd. | FOMX | Hadar Ilan CFO | 196,205 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:38 pm | N/A 2028-02-27 | Foamix Pharmaceuticals Ltd. | FOMX | Hadar Ilan CFO | 35,093 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:38 pm | N/A 2029-01-01 | Foamix Pharmaceuticals Ltd. | FOMX | Hadar Ilan CFO | 94,996 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:38 pm | N/A 2030-02-24 | Foamix Pharmaceuticals Ltd. | FOMX | Hadar Ilan CFO | 96,365 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:39 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Harsch Mutya CLO and General Counsel | 12,742 | $0 | 85,490 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:39 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Harsch Mutya CLO and General Counsel | 85,490 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:39 pm | N/A 2028-02-27 | Foamix Pharmaceuticals Ltd. | FOMX | Harsch Mutya CLO and General Counsel | 50,000 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:39 pm | N/A 2029-01-01 | Foamix Pharmaceuticals Ltd. | FOMX | Harsch Mutya CLO and General Counsel | 70,297 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:39 pm | N/A 2030-02-24 | Foamix Pharmaceuticals Ltd. | FOMX | Harsch Mutya CLO and General Counsel | 96,365 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:39 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Hirsch Stanley Director | 52,842 | $0 | 241,516 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:39 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Hirsch Stanley Director | 182,500 | $0 | 59,016 (Indirect) | View |
| 2020-03-09 Disposition | 2020-03-11 5:39 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Hirsch Stanley Director | 59,016 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:39 pm | N/A 2024-12-29 | Foamix Pharmaceuticals Ltd. | FOMX | Hirsch Stanley Director | 27,000 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:39 pm | N/A 2027-07-13 | Foamix Pharmaceuticals Ltd. | FOMX | Hirsch Stanley Director | 82,153 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:39 pm | N/A 2028-05-08 | Foamix Pharmaceuticals Ltd. | FOMX | Hirsch Stanley Director | 49,766 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:39 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | KAZANCHYAN ANNA Director | 15,714 | $0 | 43,030 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:39 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | KAZANCHYAN ANNA Director | 43,030 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:39 pm | N/A 2024-12-29 | Foamix Pharmaceuticals Ltd. | FOMX | KAZANCHYAN ANNA Director | 8,000 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:39 pm | N/A 2025-08-19 | Foamix Pharmaceuticals Ltd. | FOMX | KAZANCHYAN ANNA Director | 3,000 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:40 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Schwartz Aharon Director | 112,200 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:40 pm | N/A 2025-06-22 | Foamix Pharmaceuticals Ltd. | FOMX | Schwartz Aharon Director | 24,000 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:40 pm | N/A 2027-07-13 | Foamix Pharmaceuticals Ltd. | FOMX | Schwartz Aharon Director | 21,435 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:40 pm | N/A 2028-05-08 | Foamix Pharmaceuticals Ltd. | FOMX | Schwartz Aharon Director | 24,883 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:40 pm | N/A 2029-05-16 | Foamix Pharmaceuticals Ltd. | FOMX | Schwartz Aharon Director | 49,412 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:40 pm | N/A 2030-02-27 | Foamix Pharmaceuticals Ltd. | FOMX | Schwartz Aharon Director | 38,156 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:41 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Stuart Iain Chief Scientific Officer | 12,333 | $0 | 91,303 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:41 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Stuart Iain Chief Scientific Officer | 91,303 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:41 pm | N/A 2026-11-15 | Foamix Pharmaceuticals Ltd. | FOMX | Stuart Iain Chief Scientific Officer | 40,000 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:41 pm | N/A 2027-08-08 | Foamix Pharmaceuticals Ltd. | FOMX | Stuart Iain Chief Scientific Officer | 13,000 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:41 pm | N/A 2028-02-27 | Foamix Pharmaceuticals Ltd. | FOMX | Stuart Iain Chief Scientific Officer | 30,000 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:41 pm | N/A 2029-01-01 | Foamix Pharmaceuticals Ltd. | FOMX | Stuart Iain Chief Scientific Officer | 75,997 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:41 pm | N/A 2030-02-24 | Foamix Pharmaceuticals Ltd. | FOMX | Stuart Iain Chief Scientific Officer | 96,365 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:41 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Wiley Matthew T. Chief Commercial Officer | 35,275 | $0 | 78,799 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:41 pm | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | Wiley Matthew T. Chief Commercial Officer | 78,799 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:41 pm | N/A 2028-12-03 | Foamix Pharmaceuticals Ltd. | FOMX | Wiley Matthew T. Chief Commercial Officer | 100,000 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-11 5:41 pm | N/A 2030-02-24 | Foamix Pharmaceuticals Ltd. | FOMX | Wiley Matthew T. Chief Commercial Officer | 96,365 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-18 09:52 am | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | STERN STANLEY Director | 21,147 | $0 | 21,212 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-18 09:52 am | N/A N/A | Foamix Pharmaceuticals Ltd. | FOMX | STERN STANLEY Director | 21,212 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-18 09:52 am | N/A 2024-12-29 | Foamix Pharmaceuticals Ltd. | FOMX | STERN STANLEY Director | 27,000 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-18 09:52 am | N/A 2027-07-13 | Foamix Pharmaceuticals Ltd. | FOMX | STERN STANLEY Director | 21,562 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-18 09:52 am | N/A 2028-05-08 | Foamix Pharmaceuticals Ltd. | FOMX | STERN STANLEY Director | 24,947 | $0 | 0 (Direct) | View |
| 2020-03-09 Disposition | 2020-03-18 09:52 am | N/A 2030-02-27 | Foamix Pharmaceuticals Ltd. | FOMX | STERN STANLEY Director | 12,719 | $0 | 0 (Direct) | View |